Stage IIIC endometrioid corpus cancer includes distinct subgroups

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 112-117

  Mariani, Andrea ^a,c   Webb, Maurice J ^a   Keeney, Gary L ^a   Haddock, Michael G ^a   Aletti, Giacomo ^b   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Sacra Famiglia   (Italy)

Author keywords

Adjuvant therapy; Adnexal invasion; Endometrioid cancer; Extrauterine disease; Lymph nodes; Lymphatic metastases; Peritoneal cytology; Prognosis; Stage IIIC; Uterine serosal invasion; Vaginal invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036920081     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6789     Document Type: Article

References (29)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. FIGO stages - 1988 Revision. Gynecol Oncol 1989;35:125-6.
3. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
4. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, Ozaki Y, Murakami A, Ueda K, Taketani Y. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997;75:1836-41.
5. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence. Cancer 1993;71:3697-702.
6. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000;76:348-56.
7. Mariani A, Webb MJ, Rao SK, Lesnick TG, Podratz KC. Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer. Gynecol Oncol 2001;80:113-20.
8. Corn BW, Lanciano RM, Greven KM, Schultz DJ, Reisinger SA, Stafford PM, Hanks GE. Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 1992;24:223-7.
9. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F III, Conner W. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
10. Kim YB, Niloff JM. Endometrial carcinoma: Analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol 1993;82:175-80.
11. Faught W, Krepart GV, Lotocki R, Heywood M. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol 1994;55:51-5.
12. Rose PG, Cha SD, Tak WK, Fitzgerald T, Reale F, Hunter RE. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1992;24:229-33.
13. Podratz KC, Mariani A, Webb MJ. Staging and therapeutic value of lymphade-nectomy in endometrial cancer (editorial). Gynecol Oncol 1998;70:163-4.
14. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998;71:340-3.
15. Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: Analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999;75:211-4.
16. Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF Jr. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 1996;63:34-9.
17. Hicks ML, Piver MS, Puretz JL, Hempling RE, Baker TR, Mcauley M, Walsh DL. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus. Int J Radiat Oncol Biol Phys 1993;26:607-11.
18. Faught W, Fung MFK, Krepart GV, Lotocki RJ, Heywood MS, Genest P. Microscopic surgical stage IIIC endometrioid adenocarcinoma of the endometrium: Implications for bimodal adjuvant therapy. Int J Gynecol Cancer 1998;8:41-5.
19. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histological Typing of Female Genital Tract Tumours. 2nd Ed. Berlin: Springer-Verlag, 1994:13-8.
20. Webb MJ, editor. Mayo Clinic Manual of Pelvic Surgery. 2nd Ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
21. American Society of Anesthesiologists. New classification of physical status. Anesthesiology 1963;24:111.
22. Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstet Gynecol 1994;84:983-6.
23. Greven KM, Corn B, Lanciano RM, Case D, Randall ME. Pathologic stage III endometrial carcinoma: Significance of extrauterine sites. Radiat Oncol Invest 1996;4:122-8 (doi:10.1002/(SICI)1520-6823).
24. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol 2001;81:273-8.
25. Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol 1998;70:183-7.
26. Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Hematogenous dissemination in corpus cancer. Gynecol Oncol 2001;80:233-8.
27. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O'Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162:418-26.
28. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma - Relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 1996;60:177-83.
29. Poulsen HK, Jacobsen M, Bertelsen K, Anderson JE, Ahrons S, Bock J, Bostofte E, Engelholm SA, Holund B, Jakobsen A, Kiaer H, Nyland M, Pedersen PH, Stroyer I. Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases. Int J Gynecol Cancer 1996;6:38-43.